|
|
|
 |
| Location: Home -
Products - Reference Compounds&Impurities - Reference Compounds
|
MDA-19(MDA 19)
| Catalogue No. : |
C16371 |
| Product Name: |
MDA-19(MDA 19) |
| Synonym: |
MDA-19;MDA19;MDA 19 |
| Chemical Name: |
Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;(3Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide |
| CAS No. : |
1048973-47-2 |
| Structure : |
|
| Molecular Formula: |
C21H23N3O2 |
| Molecular Weight: |
349.43 |
| Purity: |
>98% |
| Usage: |
CB2 receptor agonist. Displays 4-fold higher affinity for the human CB2 receptor than the human CB1 receptor (Ki values are 43.3 and 162.4 nM respectively); shows 70-fold affinity for the rat CB2 receptor over the rat CB1 receptor (Ki values are 16.3 and 1130 nM respectively). Attenuates tactile allodynia in a rat model; does not affect rat locomotor activity. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
